Fri Oct 29, 2021 – 3:56 pm EDT
WASHINGTON (LifeSiteNews) — The U.S. Food & Drug Administration (FDA) gave its approval Friday to administering Pfizer’s COVID-19 vaccine to children between the ages of five and eleven, despite limited safety data and an all-but-nonexistent need.
The Associated Press reports that the FDA has given emergency-use approval to reduced doses for children, a third of the size administered to teens and adults. Final recommendations by the U.S. Centers for Disease Control & Prevention (CDC) are slated for next Tuesday, and child vaccinations could be underway by the end of next week.
Pfizer already plans to “begin shipping millions of vials of the pediatric vaccine — in orange caps to avoid mix-ups with the purple-capped doses for everyone else,” per the AP.
The news comes just days after child doses won the endorsement of the FDA’s Vaccines & Related Biological Products Advisory Committee, which raised eyebrows in large part thanks to one of the board members, Dr. Eric Rubin of Harvard, stating that “we’re never going to learn about how safe this vaccine is unless we start giving it. That’s just the way it goes.”
That comment fed into
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
